The content is available as a PDF (313.7 KB).
Bibliografía
- 1.Sociedad Española de Medicina Preventiva, Salud Pública e Higiene, Grupo de Trabajo de Vacunación en el Adulto. Guía de vacunación en el adulto.Madrid: 1995.
- 2.Pareja Bezares A., Álvarez Pasquín M.J., Batalla Martínez C., Comín Bertrán E., Gómez Marco J.J., Niño Martín V. Prevención de las enfermedades transmisibles. Aten Primaria. 1999;24(Supl 1):99–117. [PubMed] [Google Scholar]
- 3.Fingar A.R., Byron J.F. Adult immunizations. Am J Prev Med. 1998;14:156–158. doi: 10.1016/s0749-3797(97)00002-0. [DOI] [PubMed] [Google Scholar]
- 4.U.S . Preventive Services Task Force. Guide to clinical preventive services. 2. Willians & Wilkins; Baltimore: 1996. pp. 791–814. [Google Scholar]
- 5.ACIP Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep. 1997;46(RR-8):1–24. [PubMed] [Google Scholar]
- 6.Wang E. Canadian Task Force on the Periodic Health Examination. Health Canada; Ottawa (Canada): 1994. Administration of pneumococcal vaccine; pp. 386–395. [Google Scholar]
- 7.Fine M.J., Smith M.A., Carson C.A., Meffe F., Sankey S.S., Weissfeld L.A. Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled trials. Arch Intern Med. 1994;154:2666–2677. doi: 10.1001/archinte.1994.00420230051007. [DOI] [PubMed] [Google Scholar]
- 8.Hutchison B.G., Oxman A.D., Shannon H.S., Loyd S., Altmayer C.A., Thomas K. Clinical effectiveness of pneumococcal vaccine: meta-analysis. Can Fam Physician. 1999;45:2381–2393. [PMC free article] [PubMed] [Google Scholar]
- 9.Argimón J.M., Jiménez Villa J. Medidas de efecto de un tratamiento. Atención Primaria Basada en la Evidencia. 1998;5(Supl 7):45–46. [Google Scholar]
- 10.Are pneumococcal vaccines effective? Bandolier 2000 Feb [citado 10 oct 2001]; 72. Disponible en: www.jr2.ox.ac.uk/bandolier/band72/b72-4.html
- 11.Koivula I., Sten M., Leinonen M., Makela P.H. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med. 1997;103:281–290. doi: 10.1016/s0002-9343(97)00149-6. [DOI] [PubMed] [Google Scholar]
- 12.Ortqvist A., Hedlund J., Burman L.A., Elbel E., Hofer M., Leinonen M. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet. 1998;351:399–403. doi: 10.1016/s0140-6736(97)07358-3. [DOI] [PubMed] [Google Scholar]
- 13.Moore R.A., Wiffen P.J., Lipsky B.A. Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BMC Family Practice. 2000 Sep [citado 10 oct 2001];1 doi: 10.1186/1471-2296-1-1. Disponible en URL: http://biomedcentral.com/1471–2296/1/1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Salleras L., Urbizondo L., Fernández N., Comín E., Sánchez F., Batalla J. Vacunación antineumocócica en las personas mayores. Med Clin (Barc) 2001;116(Supl 1):18–23. [Google Scholar]
- 15.Honkanen P.O., Keistinen T., Miettinen L., Herva E., Sankilampi U., Laara E. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine. 1999;17:2493–2500. doi: 10.1016/s0264-410x(99)00069-9. [DOI] [PubMed] [Google Scholar]
- 16.Sisk J.E., Moskowitz A.J., Whang W., Lin J.D., Fedson D.S., McBean A.M. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA. 1997;279:1333–1339. [PubMed] [Google Scholar]
- 17.Nichol K.L., Baken L., Wuorenma J., Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med. 1999;159:2437–2442. doi: 10.1001/archinte.159.20.2437. [DOI] [PubMed] [Google Scholar]
- 18.Baltussen R.M., Ament A.J.H.A., Leidl R.M., Van Furth R. Cost-effectiveness of vaccination against pneumococcal pneumonia in The Netherlands. Eur J Pub Health. 1997;7:153–161. [Google Scholar]
- 19.De Graeve D., Lombaert G., Goossens H. Cost-effectiveness analysis of pneumococcal vaccination of adults and elderly persons in Belgium. Pharmacoeconomics. 2000;17:591–601. doi: 10.2165/00019053-200017060-00005. [DOI] [PubMed] [Google Scholar]
- 20.Ament A., Baltussen R., Duru G., Rigaud-Bully C., De Graeve D., Ortoqtvist A. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 Western European countries. Clin Infect Dis. 2000;31:444–450. doi: 10.1086/313977. [DOI] [PubMed] [Google Scholar]
- 21.The place of pneumococcal vaccination. DTB. 1998;36:73–76. doi: 10.1136/dtb.1998.361073. [DOI] [PubMed] [Google Scholar]
- 22.Álvarez M., Mayer M.A. El dilema sobre el coste-efectividad de la vacuna antineumocócica sigue abierto. MEDIFAM. 2001;11:115–120. [Google Scholar]
- 23.Cid Ruzafa J., Rodríguez Artalejo F., Martín Moreno J.M. ¿Hacia una salud pública basada en la evidencia? Med Clin (Barc) 1999;112(Supl 1):106–110. [PubMed] [Google Scholar]
- 24.Plans Rubio P., Garrido Morales P., Salleras Sanmartí L. Coste-efectividad de la vacunación neumocócica en Cataluña. Rev Esp Salud Publica. 1995;69:409–417. [PubMed] [Google Scholar]
- 25.Gaillat J., Zmiru D., Mallaret M.R., Rouman D., Bru J.P., Stahl Essai clinique du vaccin antipneumococcique chez des personnes agées vivant en institutions. Rev Epidemiol Sante Publ. 1985;33:437–444. [PubMed] [Google Scholar]
- 26.Nuorti J.P., Butler J.C., Crutcher J.M., Guevara R., Welch D., Holder P., el al An outbreak of multidrug-resistant pneumoccocal pneumonia and bacteriemia among nursing home residents. N Engl J Med. 1998;338:1861–1868. doi: 10.1056/NEJM199806253382601. [DOI] [PubMed] [Google Scholar]
- 27.Musher D.M. Pneumoccocal outbreaks in nursing homes. N Engl J Med. 1998;338:1915–1916. doi: 10.1056/NEJM199806253382610. [DOI] [PubMed] [Google Scholar]